Observational study is to demonstrate a clinically significant reduction of ionizing radiation exposure during transcatheter ablation of supraventricular tachycardias using the EnSite precision mapping system in a real-world clinical setting without compromising efficacy and safety.

Inclusion Criteria:

• Male or female patients ≥ 18 years of age
• Patient indicated for supraventricular arrhythmias ablation according to the current guidelines
• Patient is willing to provide written informed consent.

Exclusion Criteria:

• Patient is pregnant.
• Contraindications to ionizing radiation exposure
• Patient's life expectancy is less than 1 year
• Associated complex congenital heart disease
• Cardiac implantable electric devices
• Known pathological venous access to the heart

Male or female patients ≥ 18 years of age, indicated for supraventricular arrhythmias ablation according to the current local applicable guidelines